✔Rosetta has access to over half of known microRNAs (29 patents issued, 46 patent applications; cover ~1/3 of public microRNAs, access to ~3/4).
✔6 tests launched to date
✔Mid-term: Predictive biomarker work with Big Pharma and Med Tech companies (enabling personalized medicine)
✔Pipeline with focus on early detection of disease using serum-based diagnostics in areas of large unmet need.
They have patents being UNDERUTILIZED! When they start exploiting the patents, what do u think will happen?
Actually ferg, ROSG got there first check from Medicare in July and started US commercial launch( lung) in October. When rosg does report sales, I am calling for profit growth compared to last quarter, maybe not by much, but sales this quarter( april 2013)will be better than last quarter(October 2012), i guarantee it! They only have 6 test launched to date, wait til they start utilizing the other patents and launching new test I areas of unmet need.
Bottom line: the late 2012 sales efforts will be appreciated in first half of 2013... Maybe before EOY. But yes ferg: I want to see sales also.